期刊文献+

DNA甲基转移酶3A在胰腺癌组织的表达及其调控因子筛选

Expression of DNA methyltransferase 3A in pancreatic cancer and screening of its regulatory factors
原文传递
导出
摘要 目的探讨胰腺癌组织和癌旁组织中DNA甲基转移酶3A的表达水平,并采用转录组学筛选调控DNA甲基转移酶3A的微小RNA(miRNA,miR)家族。方法选取2021年6月到2023年6月新乡医学院第一附属医院住院部手术切除的胰腺癌组织和对应癌旁组织作为研究对象。采用蛋白质免疫印迹分析DNA甲基转移酶3A的表达水平。随机选取6例癌旁组织和胰腺癌组织作为研究对象,采用转录组学分析癌旁组织和胰腺癌组织中差异表达的(microRNA,miRNA),并采用生物信息学和荧光素酶报告基因分析差异表达miRNA对DNA甲基转移酶3A的调控关系。结果癌旁组织中DNA甲基转移酶3A表达水平(0.77±0.16)明显低于胰腺癌组织(1.48±0.21),差异有统计学意义(t=19.690,P<0.05)。胰腺癌组织和癌旁组织共有390个miRNA差异表达,其中上调259个,下调131个。这些miRNA主要生物学过程包括细胞增殖、细胞发育、细胞分化等;分子功能主要包括肿瘤细胞运动、细胞迁移、细胞侵袭、细胞增殖和细胞间信号转导等。发现下调的miRNA与DNA甲基转移酶3A存在碱基互补,其中差异最为显著排序前10个的miRNA分别为miR-143-3p、miR-129-5p、miR-493-5p、miR-367-3p、miR-29a-3p、miR-212-3p、miR-323A-3p、miR-5195-3p、miR-4465和miR-532-5p。癌旁组织中miR-143-3p、miR-129-5p、miR-493-5p、miR-367-3p、miR-29a-3p、miR-212-3p、miR-323a-3p、miR-5195-3p、miR-4465和miR-532-5p表达水平(1.09±0.11、0.97±0.08、1.08±0.31、1.17±0.121、1.07±0.08、1.01±0.10、0.97±0.08、1.01±0.05、0.99±0.03、1.04±0.10)明显高于胰腺癌组织(0.51±0.10、0.46±0.11、0.47±0.15、0.62±0.12、0.37±0.07、0.56±0.10、0.66±0.04、0.68±0.06、0.73±0.05、0.66±0.13),差异有统计学意义(t=11.860、12.170、5.590、9.910、21.070、9.941、11.180、14.030、13.570、7.470,P<0.05)。miRNA对照和荧光素酶报告基因共转染细胞荧光素酶活性(0.97±0.02、0.96±0.02、0.97±0.02、0.98±0.02、0.97±0.02、0.97±0.04、0.95±0.03、0.96±0.03、0.97±0.02、0.96±0.02)明显高于miR-143-3p、miR-129-5p、miR-493-5p、miR-367-3p、miR-29a-3p、miR-212-3p、miR-323a-3p、miR-5195-3p、miR-4465和miR-532-5p模拟物和荧光素酶报告基因共转染细胞荧光素酶活性(0.32±0.07、0.33±0.06、0.35±0.09、0.50±0.04、0.50±0.05、0.53±0.07、0.58±0.03、0.63±0.03、0.65±0.05、0.81±0.05),差异有统计学意义(t=22.400,24.470,16.730,24.480、20.530,14.010,21.360,19.040,15.960,6.751,P<0.05)。结论DNA甲基转移酶3a在胰腺癌组织中表达水平显著增加,miR-143-3p、miR-129-5p、miR-493-5p、miR-367-3p、miR-29a-3p、miR-212-3p、miR-323a-3p、miR-5195-3p、miR-4465和miR-532-5p等miRNA参与调控DNA甲基转移酶3a在胰腺癌组织中的表达。 Objective To investigate the expression level of DNA methyltransferase 3A in pancreatic cancer tissues and adjacent tissues,and to screen the microRNA(miRNA,miR)family that regulates DNA methyltransferase 3A by transcriptomics.Methods From June 2021 to June 2023,the pancreatic cancer tissues and corresponding adjacent tissues resected in the inpatient department of the First Affiliated Hospital of Xinxiang Medical College were selected as the research objects.The expression level of DNA methyltransferase 3A was analyzed by Western blotting.A total of 6 cases of adjacent tissues and pancreatic cancer tissues were randomly selected as research objects.The differential expression(microRNA,miRNA)in adjacent tissues and pancreatic cancer tissues was analyzed by transcriptomics,and the regulation relationship of differential expression genes to DNA methyltransferase 3A was analyzed by bioinformatics and luciferase reporter genes.The comparison of quantitative data was done by t-test.Results The expression level of DNA methyltransferase 3A in adjacent tissues(0.77±0.16)was significantly lower than that in pancreatic cancer tissues(1.48±0.21,t=19.690,P<0.05).There were 390 differentially expressed miRNAs in pancreatic cancer tissues and adjacent tissues,of which 259 were up-regulated and 131 were down-regulated.The main biological processes of these miRNAs included cell proliferation,cell development,cell differentiation.Molecular functions mainly included tumor cell movement,cell migration,cell invasion,cell proliferation,and intercellular signal transduction.It was found that downregulated miRNAs were complementary to DNA methyltransferase 3A,with the top 10 miRNAs with the most significant differences being miR-143-3p,miR-129-5p,miR-493-5p,miR-367-3p,miR-29a-3p,miR-212-3p,miR-323a-3p,miR-5195-3p,miR-4465,and miR-532-5p,respectively.The expression levels of miR-143-3p,miR-129-5p,miR-493-5p,miR-367-3p,miR-29a-3p,miR-212-3p,miR-323a-3p,miR-5195-3p,miR-4465 and miR-532-5p in adjacent cancerous tissues(1.09±0.11,0.97±0.08,1.08±0.31,1.17±0.121,1.07±0.08,1.01±0.10,0.97±0.08,1.01±0.05,0.99±0.03,1.04±0.10)were significantly higher than those of pancreatic cancer tissues(0.51±0.10,0.46±0.11,0.47±0.15,0.62±0.12,0.37±0.07,0.56±0.10,0.66±0.04,0.68±0.06,0.73±0.05,0.66±0.13,t=11.860,12.170,5.590,9.910,21.070,9.941,11.180,14.030,13.570,7.470,P<0.05).The luciferase activity of cells co-transfected with miRNA control and luciferase reporter genes(0.97±0.02,0.96±0.02,0.97±0.02,0.98±0.02,0.97±0.02,0.97±0.04,0.95±0.03,0.96±0.03,0.97±0.02,0.96±0.02)was significantly higher than that of miR-143-3p,miR-129-5p,miR-493-5p,miR-367-3p,miR-29a-3p,miR-212-3p,miR-323a-3p,miR-5195-3p miR-4465 and miR-532-5p mimetics with luciferase reporter(0.32±0.07;0.33±0.06;0.35±0.09;0.50±0.04;0.50±0.05;0.53±0.07;0.58±0.03;0.63±0.03;0.65±0.05;0.81±0.05,t=22.400,24.470,16.730,24.480,20.530,14.010,21.360,19.040,15.960,6.751,P<0.05).Conclusion The expression level of DNA methyltransferase 3a in pancreatic cancer tissue is significantly increased.miR-143-3p,miR-129-5p,miR-493-5p,miR-367-3p,miR-29a-3p,miR-212-3p,miR-323a-3p,miR-5195-3p,miR-4465 and miR-532-5p are involved in regulating the expression of DNA methyltransferase 3A in pancreatic cancer tissue.
作者 周兵 张生 李豪 席慧芳 Zhou Bing;Zhang Sheng;Li Hao;Xi Huifang(Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital of Xinxiang Medical College,Xinxiang 453100,China)
出处 《中华实验外科杂志》 CAS 2024年第1期26-30,共5页 Chinese Journal of Experimental Surgery
关键词 胰腺癌 微小RNA 转录组学 Pancreatic cancer MicroRNAs Transcriptomics
  • 相关文献

二级参考文献9

  • 1陈春美,杨卫忠,王春华,杨贤义,罗望池,任保刚,易海波,石松生,倪天.人脑胶质瘤U251耐药细胞株的建立及耐药相关蛋白的筛选[J].中华实验外科杂志,2006,23(3):375-375. 被引量:4
  • 2左石,罗剑,刘民锋,徐立宁,董泾青,郭伟,邹声泉.DNA甲基转移酶1、3b基因共下调对人胆管癌细胞生长的抑制效应[J].中华实验外科杂志,2006,23(8):912-915. 被引量:12
  • 3Gruber C J, Tschugguel W, Schneeberger C, et al. Production and ac- tions of estrogens [ J ]. N Engl J Med, 2002,346 ( 5 ) :340-352.
  • 4Giaeinti L, Claudio PP, Lopez M, et al. Epigenetic information and es- trogen receptor alpha expression in breast cancer [ J ]. Oncologist, 2006,11 (1) :1-8.
  • 5Yan L, Yang XW, Davidson NE. Role of DNA methylation and histone aeetylation in steroid receptor expression in breast cancer[ J]. J Mam- mary Gland Biol Neoplasia,2001,6(2) :183-192.
  • 6Jung Y, Park J, Kim TY, et al. Potential advantages of DNA methyl- transferase 1 ( DNMT1 ) -targeted inhibition for cancer therapy [ J ]. J Mol Med (Bed) ,2007,85(10) :1137-1148.
  • 7Shu J, Jelinek J, Chang H, et al. Silencing of bidreetional promoters by DNA methylation in tumorigenesis [ J ]. Cancer Res, 2006,66 ( 10 ) : 5077-5084.
  • 8Gopisetty G, Ramaehandran K, Singal R. DNA methylation and apop- tosis [ J]. Mol Immuno1,2006,43 ( 11 ) : 1729-1740.
  • 9王志伟,易静,陈玉英,高飞,汤雪明,李涛,邹鸿志,赵任.乳腺癌中p16基因甲基化及其与临床病理学特征的关系[J].中华实验外科杂志,2002,19(1):81-81. 被引量:5

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部